B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ENTPD5

MOLECULAR TARGET

ectonucleoside triphosphate diphosphohydrolase 5 (inactive)

UniProt: O75356NCBI Gene: 9571 compounds

ENTPD5 (ectonucleoside triphosphate diphosphohydrolase 5 (inactive)) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ENTPD5

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Anthralin1.102

About ENTPD5 as a Drug Target

ENTPD5 (ectonucleoside triphosphate diphosphohydrolase 5 (inactive)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented ENTPD5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ENTPD5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.